The efficacy of statins in the treatment of Alzheimer’s disease: a meta-analysis of randomized controlled trial

[1] Sosa-Ortiz AL(2012)Epidemiology of dementias and Alzheimer’s disease Arch Med Res 43 600-608

[2] Acosta-Castillo I(2012)The natural history of cognitive decline in Alzheimer’s disease Psychol Aging 27 1008-1017

[3] Prince MJ(2013)Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis Lancet 381 2016-2023

[4] Wilson RS(2014)The prevalence of dementia in urban and rural areas of China Alzheimers Dement 10 1-9

[5] Segawa E(2018)The cost of Alzheimer’s disease in China and re-estimation of costs worldwide Alzheimers Dement 14 483-491

[6] Boyle PA(1991)The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease Cereb Cortex 1 103-116

[7] Anagnos SE(2018)Alzheimer’s disease Eur J Neurol 25 59-70

[8] Hizel LP(2014)Alzheimer disease: lessons from immunotherapy for Alzheimer disease Nat Rev Neurol 10 188-189

[9] Bennett DA(2002)Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 1623-1630

[10] Chan KY(2009)Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study Neurology 72 1190-1191

[1] Sosa-Ortiz AL(2012)Epidemiology of dementias and Alzheimer’s disease Arch Med Res 43 600-608

[2] Acosta-Castillo I(2012)The natural history of cognitive decline in Alzheimer’s disease Psychol Aging 27 1008-1017

[3] Prince MJ(2013)Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis Lancet 381 2016-2023

[4] Wilson RS(2014)The prevalence of dementia in urban and rural areas of China Alzheimers Dement 10 1-9

[5] Segawa E(2018)The cost of Alzheimer’s disease in China and re-estimation of costs worldwide Alzheimers Dement 14 483-491

[6] Boyle PA(1991)The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease Cereb Cortex 1 103-116

[7] Anagnos SE(2018)Alzheimer’s disease Eur J Neurol 25 59-70

[8] Hizel LP(2014)Alzheimer disease: lessons from immunotherapy for Alzheimer disease Nat Rev Neurol 10 188-189

[9] Bennett DA(2002)Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 1623-1630

[10] Chan KY(2009)Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study Neurology 72 1190-1191